{
    "1702786021614649537": {
        "author_id": "5383942",
        "created_at": "2023-09-15T20:46:38.000Z",
        "edit_history_tweet_ids": [
            "1702786021614649537"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 93,
                    "normalized_text": "myelofibrosis",
                    "probability": 0.7447,
                    "start": 81,
                    "type": "Other"
                },
                {
                    "end": 160,
                    "normalized_text": "anaemia",
                    "probability": 0.7553,
                    "start": 154,
                    "type": "Other"
                },
                {
                    "end": 202,
                    "normalized_text": "splenomegaly",
                    "probability": 0.5073,
                    "start": 191,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 5,
                    "start": 0,
                    "tag": "News"
                },
                {
                    "end": 20,
                    "start": 10,
                    "tag": "investors"
                },
                {
                    "end": 31,
                    "start": 25,
                    "tag": "media"
                },
                {
                    "end": 94,
                    "start": 80,
                    "tag": "myelofibrosis"
                }
            ],
            "mentions": [
                {
                    "end": 44,
                    "id": "208120290",
                    "start": 37,
                    "username": "US_FDA"
                }
            ]
        },
        "id": "1702786021614649537",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 15085,
            "like_count": 22,
            "quote_count": 3,
            "reply_count": 1,
            "retweet_count": 8
        },
        "text": "#News for #investors and #media: The @US_FDA has approved our new treatment for #myelofibrosis that may address key manifestations of the disease, namely anaemia, constitutional symptoms and splenomegaly."
    }
}